Lupin is currently trading at Rs 447.60, up by 10.15 points or 2.32% from its previous closing of Rs 437.45 on the BSE.
The scrip opened at Rs 439.90 and has touched a high and low of Rs 454.95 and Rs 439.90 respectively. So far 177612 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 492.00 on 21-Sep-2011 and a 52 week low of Rs 363.00 on 25-Feb-2011.
Last one week high and low of the scrip stood at Rs 454.95 and Rs 428.80 respectively. The current market cap of the company is Rs 20166.15 crore.
The promoters holding in the company stood at 46.93% while Institutions and Non-Institutions held 43.44% and 9.63% respectively.
Lupin has posted a 12.91% fall in net profit of Rs 214.61 crore for the quarter ended December 31, 2011 as compared to Rs 246.42 crore for the same quarter in the previous year. Total income has increased by 16.61% from Rs 1206.42 crore for Q3FY11 to Rs 1406.85 crore in the quarter under review.
On the consolidated basis the group has posted a net profit rise of 4.92% to Rs 235.06 crore for the quarter ended December 31, 2011 as compared to Rs 224.03 crore in the same quarter last year. Total Income of the company improved by 20.39% to Rs 1822.24 crore for the quarter compared to Rs 1513.60 crore in the quarter, year ago.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1455.00 |
Dr. Reddys Lab | 5792.95 |
Cipla | 1459.85 |
Zydus Lifesciences | 1035.95 |
Lupin | 1589.90 |
View more.. |